Skip to main content

Table 1 The antibodies used in the experiments

From: eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway

Antibody

No

Company

Country

Anti-eIF6

HPA040873

Sigma

USA

Anti-β-actin

#4970

CST

USA

Anti-mTOR

#2972

CST

USA

Anti-p-mTOR Ser2448

#2971

CST

USA

Anti-Caspase-3

#9662

CST

USA

Anti-Cleaved-Caspase-3

#9664

CST

USA

Anti-CDK4

11,026–1-AP

Proteintech

USA

Anti-CDK6

14,052–1-AP

Proteintech

USA

Anti-CCND1

26,939–1-AP

Proteintech

USA

Anti-MYC

16,286–1-AP

Proteintech

USA

Anti-CTNNBL1

13,665–1-AP

Proteintech

USA

Anti-Rabbit antibody

SA00001-2

Proteintech

USA

Anti-Ki-67

ZM-0166

ZSGB-BIO

China

  1. CST: Cell Signaling Technology